Item(by='refurb', descendants=None, kids=[25185468], score=None, time=1606126740, title=None, item_type='comment', url=None, parent=25185077, text='I talked to a bunch of CROs about the cost of Phase 3 trials.  It varies, but is roughly $10,000 to $15,000 per patient year.<p>Pfizer’s trial will run for 2 years, so ~$900M for the trial alone.  That’s excluding all the work to scale up the production, regulatory filing, distribution, etc.<p>Edit: my math sucks.  $900M, not $90M')